Cargando…
Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer
Aptamers provide a potential source of alternative targeting molecules for existing antibody diagnostics and therapeutics. In this work, we selected novel DNA aptamers targeting the HER2 receptor by an adherent whole-cell SELEX approach. Individual aptamers were identified by next generation sequenc...
Autores principales: | Gijs, Marlies, Penner, Gregory, Blackler, Garth B., Impens, Nathalie R.E.N., Baatout, Sarah, Luxen, André, Aerts, An M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932547/ https://www.ncbi.nlm.nih.gov/pubmed/27213406 http://dx.doi.org/10.3390/ph9020029 |
Ejemplares similares
-
Targeted Radionuclide Therapy with A (177)Lu-labeled Anti-HER2 Nanobody
por: D'Huyvetter, Matthias, et al.
Publicado: (2014) -
Development of novel aptamers for low-density lipoprotein particle quantification
por: Klapak, Daniel, et al.
Publicado: (2018) -
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
por: Liu, Zhe, et al.
Publicado: (2012) -
Synergistic Targeting HER2 and EGFR with Bivalent
Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth
por: Xue, Lu, et al.
Publicado: (2018) -
Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic mice
por: Lecocq, Soizic, et al.
Publicado: (2018)